The 2039 A/G FSH receptor gene polymorphism influences glucose metabolism in healthy men

OBJECTIVE. To assess the role of c. 2039 A/G (p. Asp680Ser) (rs 6166) and c. -29 G/A (rs 1394205) follicle-stimulating hormone receptor ( FSHR ) gene single nucleotide polymorphisms (SNPs) in a cohort of healthy men. METHODS. One-hundred twenty-seven healthy men underwent evaluation of the anthropometric parameters, assessment of metabolic and lipid profile, measurement FSH serum levels and genotyping of both the aforementioned FSHR SNPs. Data grouped according to the FSHR rs6166 or rs1394205 genotypes underwent to statistical analysis. MAIN RESULTS. The three groups of men for each FSHR SNP did not differ statistically significantly for BMI and serum FSH levels. As for FSHR rs6166 SNP, glucose levels were significantly lower in men with the GG genotype compared to those with the AA genotype. Men with AG had lower insulin levels and HOMA index values compared with those carrying the genotype AA (p<0.05). The GG group showed a negative correlation between serum FSH levels and insulin and between serum FSH levels and HOMA index (p<0.05). In contrast, men grouped according to the FSHR rs1394205 genotype showed no significant difference in blood glucose, serum insulin levels and HOMA index. The AG group showed a negative correlation between FSH insulin and between serum FSH levels and HOMA index (p<0.05). CONCLUSION. Men with the genotype GG of the FSHR rs6166 SNP have lower blood glucose levels than those with the AA genotype. Their FSH levels inversely correlated with insulin and HOMA index. In contrast, the genotype FSHR rs6166 A/G did not reveal any role of FSH on glucose metabolism in healthy men. The inverse relationship between FSH and insulin or HOMA index in the group with the genotype GG of the FSHR rs6166 SNP suggests a possible cross-talk between FSH and insulin.